Tag archive for ‘.Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE: PLX)’
Shiri Habib-Valdhorn On Thursday, August 21st, 2014

Israeli biomedical Protalix loses half value in 1 year

– The Israeli biomedical company now faces competition for both of its drugs. – The share price of Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE: PLX) plunged 7.6% yesterday to its lowest point More...

Gali Weinreb On Sunday, March 16th, 2014

Protalix-Pfizer Collaboration Disappoints

– Sales of Protalix’s Gaucher’s disease drug to Pfizer totaled $4.4 million in 2013.  – – Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE: PLX) is not yet seeing any substantial More...

Wordpress site Developed by Fixing WordPress Problems